Arkolith/Insider Trading/ENTA/Form 4

Luly Jay R.

President and CEO, DirectorENANTA PHARMACEUTICALS INC (ENTA) · full profile →Form 4 · filed Feb 12, 2025
Net Buying
Open-Market Buys
$256K
Open-Market Sells
$0
Net Open-Market Flow
$256K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 12, 2025Buy(P)45K$5.69$256K847K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-002225) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML